share_log

Altria | 10-Q: Q3 2024 Earnings Report

Altria | 10-Q: Q3 2024 Earnings Report

奥驰亚 | 10-Q：2024财年三季报
美股SEC公告 ·  2024/10/31 19:31

Moomoo AI 已提取核心信息

Altria Group reported Q3 2024 net revenues of $6.26 billion, down 0.4% year-over-year, while adjusted diluted EPS rose 7.8% to $1.38. Smokeable products segment revenues declined 0.6% to $5.54 billion, though adjusted OCI increased 7.1% to $2.94 billion on higher pricing. Oral tobacco products saw revenues grow 5.4% to $722 million.The company reaffirmed its 2024 full-year adjusted diluted EPS guidance range of $5.00 to $5.15, representing 1-4% growth. Altria continues to make progress on its 'Moving Beyond Smoking' vision, with oral nicotine pouch on! reaching 8.9% retail share. However, the cigarette industry faces challenges from illicit e-vapor growth and inflation impacts on consumer spending.Altria completed a $2.4 billion accelerated share repurchase program in Q3 funded by proceeds from selling a portion of its ABI stake. The company raised its quarterly dividend 4.1% to $1.02 per share, targeting mid-single digit annual dividend growth through 2028. Altria aims to maintain its tobacco leadership while investing in smoke-free products to achieve its long-term vision and 2028 enterprise goals.
Altria Group reported Q3 2024 net revenues of $6.26 billion, down 0.4% year-over-year, while adjusted diluted EPS rose 7.8% to $1.38. Smokeable products segment revenues declined 0.6% to $5.54 billion, though adjusted OCI increased 7.1% to $2.94 billion on higher pricing. Oral tobacco products saw revenues grow 5.4% to $722 million.The company reaffirmed its 2024 full-year adjusted diluted EPS guidance range of $5.00 to $5.15, representing 1-4% growth. Altria continues to make progress on its 'Moving Beyond Smoking' vision, with oral nicotine pouch on! reaching 8.9% retail share. However, the cigarette industry faces challenges from illicit e-vapor growth and inflation impacts on consumer spending.Altria completed a $2.4 billion accelerated share repurchase program in Q3 funded by proceeds from selling a portion of its ABI stake. The company raised its quarterly dividend 4.1% to $1.02 per share, targeting mid-single digit annual dividend growth through 2028. Altria aims to maintain its tobacco leadership while investing in smoke-free products to achieve its long-term vision and 2028 enterprise goals.
奥驰亚集团报告2024年第三季度净收入为62.6亿，较上年同期下降0.4%，而调整后的摊薄后每股收益增长7.8%至1.38美元。可吸烟产品部门的收入下降0.6%至55.4亿，尽管调整后的其他综合收益因价格上涨而增加了7.1%至29.4亿。口腔烟草制品的收入增长5.4%至72200万。公司重申其2024财年调整后摊薄后每股收益的指导区间为5.00至5.15美元，代表1-4%的增长。奥驰亚继续在其“超越吸烟”愿景上取得进展，口腔尼古丁袋的零售市场份额达8.9%。然而，香烟行业面临来自非法电子烟增长和通货膨胀对消费者支出的影响的挑战。奥驰亚在第三季度完成了一项24亿的加速回购计划，资金来源于出售其部分ABI股份的收益。公司将季度股息提高4.1%至每股1.02美元，目标是到2028年实现中低个位数的年度股息增长。奥驰亚旨在维护其在烟草行业的领导地位，同时投资于无烟产品，以实现其长期愿景和2028年的企业目标。
奥驰亚集团报告2024年第三季度净收入为62.6亿，较上年同期下降0.4%，而调整后的摊薄后每股收益增长7.8%至1.38美元。可吸烟产品部门的收入下降0.6%至55.4亿，尽管调整后的其他综合收益因价格上涨而增加了7.1%至29.4亿。口腔烟草制品的收入增长5.4%至72200万。公司重申其2024财年调整后摊薄后每股收益的指导区间为5.00至5.15美元，代表1-4%的增长。奥驰亚继续在其“超越吸烟”愿景上取得进展，口腔尼古丁袋的零售市场份额达8.9%。然而，香烟行业面临来自非法电子烟增长和通货膨胀对消费者支出的影响的挑战。奥驰亚在第三季度完成了一项24亿的加速回购计划，资金来源于出售其部分ABI股份的收益。公司将季度股息提高4.1%至每股1.02美元，目标是到2028年实现中低个位数的年度股息增长。奥驰亚旨在维护其在烟草行业的领导地位，同时投资于无烟产品，以实现其长期愿景和2028年的企业目标。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

独立文件8  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间